Marked elevation of the creatine phosphokinase level in a patient receiving tenofovir [3]

Clinical Infectious Diseases

Volumn 35, Issue 9, 2002, Pages 1137-

  Shere Wolfe, K D ^a   Verley, J R ^a  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; CREATINE KINASE; DIDANOSINE; EFAVIRENZ; ENALAPRIL; FUROSEMIDE; GABAPENTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHADONE; STAVUDINE; TENOFOVIR; ZOLPIDEM;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CREATINE KINASE BLOOD LEVEL; GENITAL HERPES; HEPATITIS B; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; LETTER; MALE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

ADENINE; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CREATINE KINASE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS;

EID: 0036827650     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/343747     Document Type: Letter

References (3)

1. Barditch-Crovo P, Deeks SG, Collier A, et al. Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults. Antimicrob Agents Chemother 2001; 45:2733-9.
2. Bach MC. Possible drug interaction during therapy with azidothymidine and acyclovir for AIDS. N Engl J Med 1987; 316:547.
3. Tenofovir [Product Insert]. Foster City, CA: Gilead Sciences, 2001.